Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Pre-sepsis Stage: Opening a New Avenue for Early Sepsis Detection
2026-10-10

Sepsis is a life-threatening condition caused by infection-induced immune dysregulation, leading to organ dysfunction and high mortality. Although the Sepsis-3 criteria use SOFA-based organ dysfunction as the diagnostic standard, waiting until organ damage occurs may miss the optimal intervention window, contributing to millions of deaths worldwide each year. The concept of pre-sepsis(early sepsis) has emerged as a critical stage after infection onset, where immune […]

LEARN MORE
Precision Screening, Safer Transfusions: How NAT Is Reshaping Blood Safety?
2026-10-10

The consensus sets evidence-based standards for nationwide blood establishments to standardize blood screening workflows, optimize blood donor management, and strike a balance between blood safety and the rights and interests of blood donors. Furthermore, the consensus identifies the following limitations of the Guidelines for Re-entry of Blood Donors with Reactive Screening Results: “It only addresses serological test findings, without fully leveraging […]

LEARN MORE
When “Healthy” Isn’t Enough: Why Earlier Heart Risk Detection Matters?
2026-10-10

In recent years, heartbreaking headlines have become familiar: high-performing professionals in the prime of their careers, dedicated gym-goers, even trained marathon runners collapsing from sudden cardiac arrest without warning. By all appearances, they were energetic — often more disciplined about their health than most. These tragedies shatter the “health halo” we take for granted and force a stark medical question upon us: looking healthy is […]

LEARN MORE
1 in 2 May Be Infected. So How Do You Know If You Have H. pylori?
2026-09-29

In China, the prevalence of Helicobacter pylori (H. pylori, or Hp) infection is as high as 40%–50%, meaning that nearly one in two people may be infected. H. pylori infection is a major cause of chronic gastritis, peptic ulcers, and gastric cancer, making accurate diagnosis the first step toward effective management. In July 2026, the Helicobacter pylori Study Group of […]

LEARN MORE
From Viral Detection to Cancer Prevention The Role of NAT in HBV, HCV and HIV Management
2026-09-11

When cancer is mentioned, people often think of genetics, environmental factors or unhealthy lifestyles. However, what may be less known is that approximately 15%-20% of cancer cases worldwide can be attributed to chronic viral infections. Among these pathogens, HBV and HCV are major viral drivers of Hepatocellular Carcinoma (HCC), while HIV-associated immunodeficiency substantially increases the risk of several AIDS-defining and […]

LEARN MORE
×
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.
SUBMIT

Thank you!

We shall contact you soon!
Back Top